Heart Trouble Harms Men's Brains Far Sooner Than Women's
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Nov. 27, 2024 -- Men with heart risk factors tend to lose their brain health more quickly than women with similar heart risks, a new study finds.
These men face brain decline as early as their mid-50s, while women are most susceptible from their mid-60s onward, researchers report in the Journal of Neurology Neurosurgery and Psychiatry.
“These results suggest that mitigating cardiovascular risk is an important therapeutic target in the prevention of Alzheimer’s disease, and indicate that this should be addressed aggressively a decade earlier in males than in females,” concluded the research team led by senior researcher Paul Edison, a professor of neuroscience with the Imperial College London.
Heart disease risk factors like type 2 diabetes, obesity, high blood pressure and smoking have previously been associated with a higher risk of dementia, researchers said in background notes.
However, it’s not been clear when these heart health factors begin to take their toll on brain health, and whether there’s any differences between men and women, researchers noted.
For the study, researchers analyzed data on nearly 34,500 participants in the UK Biobank, an ongoing large-scale research project.
Imaging scans helped track changes in the participants’ brains over time, and researchers calculated their heart disease risk using their recorded health data.
Results showed that heart risk factors, obesity and high levels of belly fat caused a gradual loss of brain volume over several decades for both men and women.
However, men became most susceptible to these damaging effects between 55 and 74, while women were most susceptible between 65 and 74.
This risk to brain health occurred whether or not the people carried the APOE4 gene, which increases a person’s likelihood of developing Alzheimer’s disease.
The brain regions most vulnerable to heart health risks were the temporal lobes, researchers said. These regions are involved in memory and the processing of hearing, vision and emotions, and are affected early in the development of dementia.
“The detrimental impact of cardiovascular risk was widespread … highlighting how cardiovascular risk can impair a range of cognitive functions,” the researchers said.
Overall, these results indicate that tackling heart health risks by controlling blood pressure, lowering cholesterol and blood sugar, exercising and quitting smoking could help preserve a person’s brain health.
Further, men appear to have more at stake than women, researchers noted.
“Modifiable cardiovascular risk factors, including obesity, deserve special attention in the treatment/prevention of neurodegenerative diseases, including Alzheimer’s disease,” researchers wrote. “This highlights the importance of aggressively targeting cardiovascular risk factors before the age of 55 years to prevent neurodegeneration and Alzheimer’s disease, in addition to the benefit of preventing other cardiovascular events such as myocardial infarction [heart attack] and stroke.”
Sources
- BMJ Group, news release, Nov. 26, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Blood Test Might Predict Rapid Decline in Alzheimer's Patients
MONDAY, June 23, 2025 — A common blood test can flag early Alzheimer’s disease patients who are four times more likely to experience rapid brain decline, a new study...
Well-being Might Be Important To Memory
FRIDAY, June 20, 2025 — Caring for your emotional health might also help keep your memory sharp, a new study says. People with higher levels of well-being have a reduced...
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
WEDNESDAY, June 18, 2025 — Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives Lilly a potential...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.